Inovio Clinical Trials: Cancer

Inovio Biomedical is involved with partners in the following ongoing clinical trials for the treatment of cancers. Patients are being recruited for these trials as detailed below.

Indication: Breast, colorectal, ovarian, or non-small cell lung cancer

Treatment: V930/V932 + electroporation

Trial Stage: Phase I

• Expressing the antigens HER-2 and/or CEA
• Study design: Treatment, non-randomized, open label, uncontrolled, single group assignment, safety/efficacy study
• For more information: clinical.trials@inovio.com
• Clinical trial description:
  http://www.abedia.com/wiley/record_detail.php?ID=1259